Chloroquine stabilizes hepatic glucocorticoid receptors

Area of Science:

• Biochemistry
• Pharmacology

Background:

• Glucocorticoid receptors are crucial for cellular regulation.
• Stabilizing these receptors is vital for accurate biochemical analysis.
• Molybdate is a common but potentially interfering stabilizing agent.

Purpose of the Study:

• To investigate the stabilizing effects of chloroquine on rat hepatic glucocorticoid receptors.
• To compare chloroquine's efficacy with traditional stabilizing agents like molybdate.

Main Methods:

• In vitro incubation of rat hepatic cytosol with chloroquine at varying concentrations.
• Assessment of receptor stability at different temperatures (4°C and 25°C).
• Evaluation of chloroquine's effect on KCl-induced receptor inactivation.
• Analysis of glucocorticoid-receptor complex sedimentation in sucrose density gradients.

Main Results:

• Chloroquine significantly stabilized unbound hepatic glucocorticoid receptors in vitro for 2 hours at 25°C.
• Stabilization was concentration-dependent, with significant effects at 0.3 mM and optimal at 3 mM.
• Chloroquine reduced KCl-induced receptor inactivation and stabilized steroid-prebound complexes.
• Unlike molybdate, chloroquine did not alter receptor complex sedimentation patterns.

Conclusions:

• Chloroquine demonstrates significant potential as a stabilizing agent for glucocorticoid receptors.
• Its unique properties may offer advantages over molybdate in receptor studies.
• Chloroquine may be valuable for glucocorticoid receptor quantitation, characterization, and purification.